The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept
18 November 2019

Darnitsa Presented Rebranding Results at the World’s Largest Pharmaceutical Exhibition in Frankfurt

18 November 2019

The Pharmaceutical Firm “Darnitsa” took part in the international specialized exhibition CPhI Worldwide 2019, which was held in Frankfurt (Germany) from November 5 to 7.

CPhI Worldwide is the platform that forms the agenda of the global pharmaceuticals industry and determines future trends. It provides opportunities for searching for new solutions in the business and expansion of the global market.

This year’s exhibition united over 2,500 companies from all over the world. Only the Olympic Games can match CPhI by the representation geography – 45,000 participants from 165 countries came to the exhibition. It was not until fairly recently that Ukrainian companies started participating in CPhI Worldwide.

In Frankfurt “Darnitsa” presented its brand portfolio, showed openness and readiness to cooperate with international players in the area of development and manufacture of generic products and to develop the export potential.

Andrii Obrizan, General Director of the Pharmaceutical Firm “Darnitsa”:

“This year’s CPhI Worldwide is already the fourth for us. But this time in Frankfurt we’ve presented the new “Darnitsa”. We have recently presented the rebranding of “Darnitsa” in Ukraine, and now our new logo, values and pack design of medicinal products have received a positive appraisal also among the representatives of the international pharmaceuticals industry. We see the exhibition as an opportunity to consolidate business, learn the latest news and trends in the industry, meet important players and present our capabilities to potential partners and customers. The participation in CPhI brought us another step closer to our strategic objective – creation of the international pharmaceutical brand.”

Share:
Specialized edition for medical institutions and doctors.